Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
MT-1186
Tanabe Pharma
Healthy Adult Subjects
1 trial -
MTX110
Biodexa Pharmaceuticals Plc
Recurrent Glioblastoma
1 trial -
MUNC13.4-CD34 suspension, MUNC13.4-T3 suspension
Pari Pharma GmbH
Familial Hemophagocytic Lymphohistiocytosis (FHL)
1 trial -
MarzAA (marzeptacog alfa [activated])
CATALYST PHARMACEUTICALS, INC.
Hemophilia A
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Hepatic Insufficiency
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Waldenstrom's Macroglobulinemia
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Healthy Participants
1 trial -
Meloxicam 15 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Methotrexate - Amneal
Amneal Pharma Europe Ltd
Psoriasis
1 trial -
Methotrexate PK (in combination with Novobiocin) in RA patients
Lacuna Pharma Pty Ltd
Rheumatoid arthritis
1 trial -
Metronidazole
Teva Pharma GmbH
Healthy
1 trial -
Microgestinยฎ
IRONWOOD PHARMACEUTICALS INC
Healthy Volunteers
1 trial -
Midazolam
ENANTA PHARMACEUTICALS INC
NASH
1 trial -
Midazolam Syrup
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects
1 trial -
Minzasolmin, UCB0599 PRD4385815
Lacuna Pharma Pty Ltd
Healthy Participants
1 trial -
Mirtazapine 15 mg (Orally Disintegrating) Tablets
Teva Pharma GmbH
Healthy
2 trials -
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Mycophenolate Mofetil
Teva Pharma GmbH
Healthy
4 trials -
NCO-48 Fumarate
LIGAND PHARMACEUTICALS INC
Hepatitis B
1 trial -
NCO-48 Fumarate 4 mg
LIGAND PHARMACEUTICALS INC
Chronic Hepatitis B
1 trial -
NKTR-214 (Cohort A)
INOVIO PHARMACEUTICALS, INC.
Metastatic Castration-resistant Prostate Cancer
1 trial -
NP101
Teva Pharma GmbH
Compare Bioequivalence Patches Previously Used in the NP101-007 Study
1 trial -
NPC-22
Belpharma s.a.
Healthy Adult Subjects
1 trial -
NPC-22
Belpharma s.a.
Safety and Pharmacokinetics
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources